| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/28/2001 | US6280932 High affinity nucleic acid ligands to lectins |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/23/2001 | WO2001061353A1 Method of detecting subject to be analyzed |
| 08/23/2001 | WO2001060835A1 Purine derivatives |
| 08/23/2001 | WO2001060834A1 Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both |
| 08/23/2001 | WO2001060383A1 METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE |
| 08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/23/2001 | WO2001060315A2 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | US20010016652 Providing a purine or pyrimidine base containing nucleoside with acid labile hydroxyl protecting group and a base labile hydroxy protecting group substitutions, deblocking hydroxy group, treating with phosphonate compound, condensing agent |
| 08/23/2001 | US20010016329 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/23/2001 | CA2400274A1 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/22/2001 | EP1125945A1 Reversible photocoupling nucleic acid and phosphoroamidite |
| 08/22/2001 | EP1124839A2 Nucleosides with anti-hepatitis b virus activity |
| 08/22/2001 | EP1124838A2 Nucleic acid labeling compounds |
| 08/22/2001 | EP1124565A1 Beta-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/21/2001 | US6277982 Alkylation of alcohols, amines, thiols and their derivatives by cyclic sulfate intermediates |
| 08/21/2001 | US6277830 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon |
| 08/21/2001 | US6277603 Peptide nucleic acid (pna); the dna portion is composed of subunits of at least one 2'-deoxynucleotides; increased nuclease resistance; activate rnase h enzyme, use for in vitro modification of rna |
| 08/21/2001 | CA2056596C 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases |
| 08/16/2001 | WO2001058920A2 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| 08/16/2001 | WO2001058917A1 Process for the preparation of trifluorothymidine derivatives |
| 08/16/2001 | US20010014735 Hybrid stabilization |
| 08/16/2001 | US20010014453 Such as N,N-bis(2-trimethoxysilylpropyl)ethanolamine; for silanation of surfaces such as glass and subsequent immobilization of nucleic acids and polypeptides |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | CA2366513A1 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing a nucleoside |
| 08/15/2001 | CN1069648C Process for large-scale preparation of 2',3'-didehydro-2',3-dideoxynucleosides |
| 08/14/2001 | US6274563 Administering as antidiabetic agent |
| 08/10/2001 | CA2354888A1 Preparation process for trifluorothymidine derivatives |
| 08/09/2001 | WO2001056581A1 Powdered preparation for inhalation and powder inhalant containing the same packed |
| 08/09/2001 | WO2001016312A3 Nucleic acid based modulators of gene expression |
| 08/09/2001 | US20010012618 Useful for enzymatic cleavage of RNA or single stranded DNA, and also as antisense oligonucleotides; improved stability and activity |
| 08/08/2001 | EP1121372A1 Adenine derivatives |
| 08/08/2001 | EP1121371A1 Nucleotide compounds including a rigid linker |
| 08/08/2001 | EP1121370A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 08/08/2001 | EP1121369A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 08/08/2001 | EP1121366A1 Prodrugs of phosphorous-containing pharmaceuticals |
| 08/08/2001 | CN1069322C Antisense digonucleotide and use thereof |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/07/2001 | US6271370 Reacting 2',3'-o-alkylidene .beta.-furanosyl halide compound with heterocycle having ring nitrogen capable of forming covalent bond with anomeric carbon of furanose or furanose analog in dimethyl sulfoxide in presence of strong base |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271231 Pharmaceutically active compounds |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/07/2001 | US6271195 Aminimide-containing molecules and materials as molecular recognition agents |
| 08/07/2001 | CA2085345C Pyrimidine nucleoside derivatives |
| 08/02/2001 | WO2001055451A1 C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support |
| 08/02/2001 | WO2001055160A1 Purification of oligonucleotides |
| 08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
| 08/02/2001 | WO2001016149A3 2-azapurine compounds and their use |
| 08/02/2001 | WO2000036151A9 A heterogeneous assay for pyrophosphate detection |
| 08/02/2001 | US20010011139 Polynucleotides labeled with dibenzorhodamine dyes |
| 08/02/2001 | US20010011075 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 08/02/2001 | DE10003631A1 New nucleoside derivatives with photolabile protecting groups, useful in oligonucleotide synthesis, particularly on solid phases, e.g. for hybridization testing |
| 08/02/2001 | CA2398749A1 Purification of oligonucleotides |
| 08/02/2001 | CA2398435A1 Novel ligands and methods for preparing same |
| 08/01/2001 | EP1119635A1 Non-homogeneous systems for the resolution of enantiomeric mixtures |
| 08/01/2001 | EP1119577A2 Synthesis of oligosaccharides, reagents and methods related thereto |
| 08/01/2001 | CN1306511A Novel heterocyclic compounds |
| 07/31/2001 | US6268490 Bicyclonucleoside and oligonucleotide analogues |
| 07/31/2001 | US6268374 Uracil reductase inactivators |
| 07/31/2001 | US6268132 Amplification, sequencing, replication, transcripition, enzymatic digestion, hybridization, medical diagnosis |
| 07/31/2001 | CA2121144C Oligonucleotides having chiral phosphorus linkages |
| 07/26/2001 | WO2001053314A1 Antisense modulation of daxx expression |
| 07/26/2001 | WO2001053307A1 2'-arabino-fluorooligonucleotide n3'→p5'phosphoramidates: their synthesis and use |
| 07/25/2001 | EP1117838A1 A method for analyzing polynucleotides |
| 07/25/2001 | CN1304939A Process for preparing nucleotide |
| 07/24/2001 | US6265569 3'-Deoxyribonucleotide derivatives |
| 07/24/2001 | US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups |
| 07/19/2001 | WO2001051661A2 A universal nucleic acid amplification system for nucleic acids in a sample |
| 07/19/2001 | WO2001002020A3 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008883 Measuring agonist stimulated (35S)GTP gamma S binding to G proteins by compound, measuring extent of agonist stimulated (35S)GTP gamma S binding to G proteins by a full adenosine A1 receptor agonist, selecting compounds with 65-95% binding |
| 07/18/2001 | EP0819134B1 Covalently cross-linked oligonucleotides, method for preparing same, and synthon used therein |
| 07/18/2001 | CN1304413A Form VI5,6-dichloro-2-(isopropylamino)-1-(&beta-L-ribofuranosyl)-1H-benzimidazole |
| 07/18/2001 | CN1303859A Carbazole derivatives their preparing process and pharmaceutical composition containing them |
| 07/18/2001 | CN1068602C Pyrimidine nucleoside derivatives |
| 07/17/2001 | US6262251 Product anchored sequencial synthesis (pass); an anchor group attached to the 5' end of the growing oligonucleotide product allows the coupled product to be separated from unreacted starting materials |
| 07/17/2001 | US6262241 Antisense compounds which cleave phosphorodiester bonds and improve pharmacodynamic and pharmacokinetic properties of oligonucleotides, useful in diagnosing diseases |
| 07/17/2001 | US6262216 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization |
| 07/17/2001 | US6261813 Two step enzymatic acylation |
| 07/17/2001 | US6261776 Nucleic acid arrays |
| 07/17/2001 | US6261774 Truncation selex method |
| 07/12/2001 | WO2001049700A1 Imidazopyrimidine nucleoside analogues with anti-hiv activity |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2000078774A3 Induction of pharmacological stress with adenosine receptor agonists |
| 07/12/2001 | US20010007905 Nucleic acids labelled with extended rhodamine dyes |
| 07/12/2001 | US20010007751 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes |
| 07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/11/2001 | EP1114827A1 Novel nucleic acid base pair |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
| 07/11/2001 | CN1303390A Novel crystalline forms for antiviral benzimidazole compound |
| 07/11/2001 | CN1302612A Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 07/10/2001 | US6258795 Compounds for treatment of diabetes, cardiovascular disorders, nervous system disorders and respiratory system disorders |
| 07/10/2001 | US6258794 Antidepressants and compounds that inhibit adenosine uptake |
| 07/10/2001 | US6258793 Modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals |